Abstract Details
Activity Number:
|
217
|
Type:
|
Topic Contributed
|
Date/Time:
|
Monday, August 4, 2014 : 2:00 PM to 3:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract #313090
|
|
Title:
|
Risk-Based Monitoring and Statisticians: An Evolving Role in Methods, Collaboration, Education, and Implementation
|
Author(s):
|
Rakhi Kilaru*+
|
Companies:
|
PPD
|
Keywords:
|
|
Abstract:
|
Building quality and risk management approaches into the scientific design and operational conduct of clinical trials can mitigate risks and facilitate detection of quality compromising issues and prevention. TransCelerate BioPharma Inc., a non-profit entity with members from pharmaceutical and biotechnology companies continues to develop and build on a methodology that shifts monitoring processes to comprehensive risk-driven monitoring. In light of the most recent recommendations and methodology, the role of a statistician is evolving as an integral component to risk assessment, mitigation and monitoring tasks. A higher, different level of engagement and collaboration is urgently required of a statistician within the cross functional clinical setting in developing the integrated quality and risk management plan (IQRMP), in educating and collaborating with data scientists, clinical scientists and operational staff for successful roll-out of a risk based monitoring plan.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2014 program
|
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.